World Health Organization Global Health Sector Strategy on Sexually Transmitted Infections: An Evidence-to-Action Brief for Colombia

Authors

  • Melanie Taylor
  • Monica Alonso-González
  • Bertha Gómez
  • Eline Korenromp
  • Nathalie Broutet

DOI:

https://doi.org/10.18597/rcog.3071

Keywords:

Colombia, syphilis, congenital syphilis, chlamydia, gonorrhoea, sexually transmitted infections, infertility, stillbirth, antimicrobial resistance, prevention, strategy, policy, public health

Abstract

Curable and incurable sexually transmitted infections (STI) are acquired by hundreds of millions of people worldwide each year. Undiagnosed and untreated STIs cause a range of negative health outcomes including adverse birth outcomes, infertility and other long term sequelae such us cervical cancer. In 2016, the World Health Organization (WHO) launched the Global STI Strategy (2016-2021). The WHO Global STI Strategy’s public health approach focuses on three causative organisms of STIs that need immediate action and for which cost-effective interventions exist: (a) Neisseria gonorrhoea as a cause of infertility, a risk factor for coinfection with other STIs and because of increasing bacterial resistance to antibiotic treatment, (b) Treponema pallidum given the contribution of syphilis to adverse birth outcomes including stillbirth and neonatal death and (c) Human papillomavirus due to its link to cervical cancer. The range of actions recommended for countries includes: (a) strengthening surveillance, with program monitoring and progress evaluation, (b) STI prevention, (c) early diagnosis of STIs, (d) patient and partner management, and (e) approaches to reach the most vulnerable populations. This summary describes the WHO Global STI Strategy alongside findings from a STI surveillance workshop held in Colombia in May of 2017. Observations related to the Global STI Strategy and findings from the STI estimation workshop are described here for stakeholders in Colombia to consider as they identify opportunities to improve STI services and surveillance.

Author Biographies

Melanie Taylor

Department of Reproductive Health and Research, World Health Organization, Geneva (Switzerland). Centers for Disease Control and Prevention, Division of STD Prevention, Atlanta (USA).

Monica Alonso-González

Pan American Health Organization, Washington (USA).

Bertha Gómez

Pan American Health Organization, Bogotá (Colombia).

Eline Korenromp

Avenir Health, Geneva (Switzerland).

Nathalie Broutet

Department of Reproductive Health and Research, World Health Organization, Geneva (Switzerland)

References

World Health Organization. Global Health Sector Strategy on Sexually Transmitted Infections 2016-2021 [visited 2017 Aug 31]. Available from: http://www.who.int/reproductivehealth/publications/rtis/ghss-stis/en/.

World Health Organization. Global Health Sector Strategy on HIV 2016-2021 [visited 2017 Aug 31]. Available from: http://www.who.int/hiv/strategy2016-2021/ghss-hiv/en/.

World Health Organization. Global Health Sector Strategy on Hepatitis 2016-2021 [visited 2017 Aug 31]. Available from: http://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/

United Nations. The 2030 agenda for sustainable development [visited 2017 Jul 11]. Available from: https://sustainabledevelopment.un.org/content/documents/21252030%20Agenda%20for%20Sustainable%20Development%20web.pdf

World Health Organization. Global Strategy for Women’s Children’s and Adolescents’ Health (2016-2030) [visited 2017 Jul 11]. Available from: http://www.who.int/life-course/partners/global-strategy/global-strategy-2016-2030/en/

World Health Organization. A tool for strengthening STI surveillance at the country level, 2015 [visited 2017 Jul 11]. Available from: http://www.who.int/reproductivehealth/publications/rtis/sti-surveillance/en/

World Health Organization. Global action plan on antimicrobial resistance [visited 2017 Jul 11]. Available from: http://www.who.int/antimicrobial-resistance/global-action-plan/en/

Korenromp EL, Mahiané G, Rowley J, Nagelkerke N, Abu-Raddad L, Ndowa F, et al. Estimating prevalence trends in adult gonorrhoea and syphilis in low- and middle-income countries with the Spectrum-STI model: results for Zimbabwe and Morocco from 1995 to 2016. Sex Transm Infect. 2017; pii: sextrans-2016-052953. doi: 10.1136/sextrans-2016-052953.

Avenir Health. Spectrum software and manual [visited 2017 Aug 31]. Available from: http://avenirhealth.org/software-spectrum.php.

Korenromp EL, Rios Hincapie CY, Sabogal Apolinar AL, Caicedo S, Cuellar D, Cardenas Cañon IM, et al. Adult syphilis, chlamydia and gonorrhea prevalence and incidence, and congenital syphilis incidence in Colombia, 1995-2016 – estimates using the Spectrum-STI model (in preparation).

How to Cite

1.
Taylor M, Alonso-González M, Gómez B, Korenromp E, Broutet N. World Health Organization Global Health Sector Strategy on Sexually Transmitted Infections: An Evidence-to-Action Brief for Colombia. Rev. colomb. obstet. ginecol. [Internet]. 2017 Sep. 29 [cited 2024 May 17];68(3):193-201. Available from: https://revista.fecolsog.org/index.php/rcog/article/view/3071

Downloads

Download data is not yet available.

Downloads

Published

2017-09-29

Issue

Section

Reflection Article
QR Code

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views

Some similar items: